| A Research Study of How Oral Semaglutide Tablets Work in Healthy People Who Are Chinese (NCT04016974) | Novo Nordisk A/S | 2019-10-08 |
| A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity (NCT04102189) | Novo Nordisk A/S | 2019-10-07 |
| A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide Tablets (NCT04109508) | Novo Nordisk A/S | 2019-10-02 |
| A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 Diabetes (NCT04109547) | Novo Nordisk A/S | 2019-10-01 |
| A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets (NCT04097600) | Novo Nordisk A/S | 2019-09-30 |
| A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in France, as Part of Local Clinical Practice (SURE FRANCE) (NCT04083820) | Novo Nordisk A/S | 2019-09-16 |
| Research Study to Investigate the Effect of NNC0174-0833 on a Birth Control Pill in Women Who Are Not Able to Become Pregnant (NCT04074174) | Novo Nordisk A/S | 2019-09-12 |
| Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity (NCT04074161) | Novo Nordisk A/S | 2019-09-11 |
| Post-marketing Surveillance (Use Result Surveillance) With Refixia® (NCT03875547) | Novo Nordisk A/S | 2019-08-23 |
| A Research Study Investigating How NNC0385-0434 is Tolerated in People With or Without High Cholesterol Levels (NCT04058834) | Novo Nordisk A/S | 2019-08-20 |
| Research Study to Investigate How a Study Medicine (NNC9204- 1177) Affects Blood Levels of Other Medicines in Healthy People (NCT04059367) | Novo Nordisk A/S | 2019-08-15 |
| A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 Diabetes (NCT04032197) | Novo Nordisk A/S | 2019-08-12 |
| A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice (NCT04067999) | Novo Nordisk A/S | 2019-08-05 |
| A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes (NCT04017832) | Novo Nordisk A/S | 2019-07-29 |
| A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Works in People With Type 2 Diabetes in Local Clinical Practice (NCT04042441) | Novo Nordisk A/S | 2019-07-29 |
| A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity (NCT04012255) | Novo Nordisk A/S | 2019-07-15 |
| A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity (NCT04010786) | Novo Nordisk A/S | 2019-07-11 |
| A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day (NCT03878446) | Novo Nordisk A/S | 2019-07-04 |
| A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity (NCT04007107) | Novo Nordisk A/S | 2019-06-27 |
| Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA) (NCT03972345) | Novo Nordisk A/S | 2019-06-21 |
| A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes (NCT03989232) | Novo Nordisk A/S | 2019-06-19 |
| A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage (NCT03987451) | Novo Nordisk A/S | 2019-06-18 |
| A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease (NCT03819153) | Novo Nordisk A/S | 2019-06-17 |
| A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes (NCT03914326) | Novo Nordisk A/S | 2019-06-17 |
| A Study to Look at How Safe NNC0268-0965 is in Healthy People and People With Type 1 Diabetes (NCT03965013) | Novo Nordisk A/S | 2019-06-05 |
| Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition (NCT03926117) | Novo Nordisk A/S | 2019-06-03 |
| A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS) (NCT03929679) | Novo Nordisk A/S | 2019-05-28 |
| A Study of All-Cause and Cardiovascular Mortality in Type 2 Diabetes Patients Using Basal Insulin Detemir and Glargine (NCT03960814) | Novo Nordisk A/S | 2019-05-21 |
| A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day (REAL4) (NCT03811535) | Novo Nordisk A/S | 2019-05-20 |
| A Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine (NCT03922750) | Novo Nordisk A/S | 2019-05-09 |
| A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before (NCT03951805) | Novo Nordisk A/S | 2019-05-09 |
| A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes (NCT03811561) | Novo Nordisk A/S | 2019-05-08 |
| A Research Study of How Overdosing of a New Once Weekly Medicine NNC0148-0287 C (Insulin 287) Influences the Blood Sugar Level in People With Type 2 Diabetes (NCT03945656) | Novo Nordisk A/S | 2019-05-07 |
| A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in United Kingdom, as Part of Local Clinical Practice (SURE UK) (NCT03876015) | Novo Nordisk A/S | 2019-05-01 |
| A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN (NCT03745924) | Novo Nordisk A/S | 2019-04-01 |
| A Study to Compare the Uptake Into the Blood of Two Strengths of Somapacitan After Injection Under the Skin in Healthy Subjects (NCT03905850) | Novo Nordisk A/S | 2019-03-29 |
| A Research Study Looking at How Victoza® Works in People With Type 2 Diabetes in Iran, Followed in Local Clinical Routine (NCT03888157) | Novo Nordisk A/S | 2019-03-10 |
| Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity. (NCT03856047) | Novo Nordisk A/S | 2019-03-01 |
| Research Study to Look at Fast-acting Insulin Aspart With the Insulin Pump System 'iLet™' in Adults With Type 1 Diabetes (NCT03816761) | Novo Nordisk A/S | 2019-02-25 |
| A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesity (NCT03842202) | Novo Nordisk A/S | 2019-02-15 |
| A Research Study, Looking at How Xultophy® Works in People With Type 2 Diabetes in Local Clinical Practice in United Arab Emirates (NCT03823339) | Novo Nordisk A/S | 2019-01-29 |
| STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or Obesity (NCT03811574) | Novo Nordisk A/S | 2019-01-21 |
| A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Together (NCT03789578) | Novo Nordisk A/S | 2019-01-17 |
| A Study of People With Type 2 Diabetes Who Have Diseases That Affect the Heart and Blood Vessels. The Study Will Also Look at the Treatment of a Group of These People in Hospitals in Portugal (NCT03797885) | Novo Nordisk A/S | 2019-01-15 |
| Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity (NCT03799198) | Novo Nordisk A/S | 2019-01-07 |
| A Research Study of How NNC0174-0833 Behaves in Japanese and Caucasian Volunteers Who Are Normal Weight, Overweight or With Obesity (NCT03787225) | Novo Nordisk A/S | 2019-01-07 |
| A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in Saudi Arabia (NCT03785522) | Novo Nordisk A/S | 2018-12-23 |
| A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6) (NCT03741881) | Novo Nordisk A/S | 2018-12-18 |
| An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 Diabetes (NCT03811288) | Novo Nordisk A/S | 2018-12-10 |
| A Research Study of How Different Amounts of a New Medicine NNC0148-0287 C (Insulin 287) Works on the Blood Sugar of People Who Are Japanese With Type 1 Diabetes When Given Once a Week (NCT03766854) | Novo Nordisk A/S | 2018-12-07 |
| An International Survey of the Occurrence of Diseases That Affects the Heart and Blood Vessels Among People With Type 2 Diabetes (NCT03786406) | Novo Nordisk A/S | 2018-12-03 |
| A Research Study of How Different Doses of a New Medicine NNC0148-0287 C (Insulin 287) Work on the Blood Sugar in People With Type 1 Diabetes When it is Taken Once a Week (NCT03723772) | Novo Nordisk A/S | 2018-11-29 |
| A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes. (NCT03751657) | Novo Nordisk A/S | 2018-11-29 |
| RESILIENT: A Research Study, Looking at How Ryzodeg® Works in People With Type 2 Diabetes in Local Clinical Practice in Japan (NCT03745157) | Novo Nordisk A/S | 2018-11-21 |
| A Research Study of How a New Medicine NNC0148-0287 C (Insulin 287) Works in the Body of People With Kidney Problems (NCT03723785) | Novo Nordisk A/S | 2018-11-09 |
| A Canadian Study of the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus (NCT03674866) | Novo Nordisk A/S | 2018-10-29 |
| A Research Study Looking at How Faster Aspart Injected in Double Concentration Works in the Body of People With Type 1 Diabetes Mellitus (NCT03723759) | Novo Nordisk A/S | 2018-10-26 |
| Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity (NCT03574597) | Novo Nordisk A/S | 2018-10-24 |
| A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or Obese (NCT03707990) | Novo Nordisk A/S | 2018-10-15 |
| Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity (NCT03693430) | Novo Nordisk A/S | 2018-10-05 |
| Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy (NCT03672617) | Novo Nordisk A/S | 2018-10-02 |
| A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO Study (NCT03687827) | Novo Nordisk A/S | 2018-10-02 |
| A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (NCT03689374) | Novo Nordisk A/S | 2018-10-01 |
| Adverse Event Data Collection From External Registries on Nonacog Beta Pegol (NCT03690336) | Novo Nordisk A/S | 2018-10-01 |
| A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia (NCT03660774) | Novo Nordisk A/S | 2018-09-27 |
| Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity (NCT03661879) | Novo Nordisk A/S | 2018-09-12 |
| A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice (SURE SWITZERLAND) (NCT03631186) | Novo Nordisk A/S | 2018-09-12 |
| A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Denmark and Sweden, as Part of Local Clinical Practice (SURE DENMARK/SWEDEN) (NCT03648281) | Novo Nordisk A/S | 2018-08-24 |
| Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy Men (NCT03638778) | Novo Nordisk A/S | 2018-08-17 |
| First Research Study of the Possible New Medicine NNC0113-2023 in Healthy Men. (NCT03617081) | Novo Nordisk A/S | 2018-08-09 |
| A Trial to Compare Blood Concentration Levels of Semaglutide Following Subcutaneous Injections of Semaglutide 1 mg by 2 Different Devices (the DV3372 Device and by the PDS290 Semaglutide Pen-injector) (NCT03611322) | Novo Nordisk A/S | 2018-08-08 |
| Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program (NCT03611582) | Novo Nordisk A/S | 2018-08-01 |
| A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese (NCT03600480) | Novo Nordisk A/S | 2018-07-25 |
| A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection Tools (NCT03598621) | Novo Nordisk A/S | 2018-07-23 |
| Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial (NCT03596450) | Novo Nordisk A/S | 2018-07-13 |
| A Regulatory Post-marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda®(Liraglutide 3.0 mg) in Obese Patients and Overweight Patients With Obesity-related Comorbidities in Routine Clinical Practice in Korea. (NCT03560336) | Novo Nordisk A/S | 2018-07-05 |
| Study Investigating Novoeight®/NovoEight® (Turoctocog Alfa) in Mexican Haemophilia A Patients (NCT03179748) | Novo Nordisk A/S | 2018-06-20 |
| A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese (NCT03574584) | Novo Nordisk A/S | 2018-06-18 |
| Evaluation of Safety Following Immune Tolerance Induction Treatment With Turoctocog Alfa in Patients With Haemophilia A Following Inhibitor Development in NN7170-4213 Trial (NCT03588741) | Novo Nordisk A/S | 2018-06-12 |
| Awareness, Care & Treatment In Obesity Management - An International Observation (NCT03584191) | Novo Nordisk A/S | 2018-06-04 |
| Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity (NCT03552757) | Novo Nordisk A/S | 2018-06-04 |
| Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity (NCT03548987) | Novo Nordisk A/S | 2018-06-04 |
| STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity (NCT03548935) | Novo Nordisk A/S | 2018-06-04 |
| A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A (NCT03528551) | Novo Nordisk A/S | 2018-04-30 |
| In Market Utilisation of Liraglutide Used for Weight Management in the UK: a Study in the CPRD Primary Care Database (NCT03479762) | Novo Nordisk A/S | 2018-04-20 |
| A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice (NCT03457012) | Novo Nordisk A/S | 2018-03-29 |
| Study on How Fiasp® Can Influence Blood Sugar Levels of type1 Diabetic Patients in Their Daily Lives, With the Help of the Freestyle Libre® Device (NCT03450863) | Novo Nordisk A/S | 2018-03-22 |
| A Trial Investigating the Effect of Probenecid and Ciclosporin on the Concentrations of SNAC in Healthy Subjects (NCT03466567) | Novo Nordisk A/S | 2018-03-15 |
| A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity (NCT03479892) | Novo Nordisk A/S | 2018-03-13 |
| Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks Period (NCT03449342) | Novo Nordisk A/S | 2018-03-01 |
| Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome) (NCT03435627) | Novo Nordisk A/S | 2018-02-26 |
| First Research Study to Compare a Possible New Medicine NNC9204-1513 to the Medicine Glucagon, in Healthy People. (NCT03444467) | Novo Nordisk A/S | 2018-02-05 |
| A Regulatory Post Marketing Surveillance (rPMS) Study of Ryzodeg® FlexTouch® (Insulin Degludec /Insulin Aspart) to Evaluate Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice in Korea (NCT03416855) | Novo Nordisk A/S | 2018-01-31 |
| A Trial Comparing the Pharmacokinetic Properties of Fast-acting Insulin Aspart Between Children, Adolescents and Adults With Type 1 Diabetes (NCT03407599) | Novo Nordisk A/S | 2018-01-08 |
| Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE) (NCT03430154) | Novo Nordisk A/S | 2017-12-01 |
| A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Liver (NCT03357380) | Novo Nordisk A/S | 2017-11-28 |
| Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes (NCT03377699) | Novo Nordisk A/S | 2017-11-22 |
| A Non-interventional Study of Ability and Willingness to Pay for BIAsp 30 in a Real World Population With Type 2 Diabetes Mellitus (T2DM) (NCT03374774) | Novo Nordisk A/S | 2017-11-13 |
| Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity (NCT03308721) | Novo Nordisk A/S | 2017-10-16 |
| A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects (NCT03292185) | Novo Nordisk A/S | 2017-09-29 |